Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
<tr> | <tr> | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
| + | =====Insulin===== | ||
| + | *[[Lantus]] - Generic: [[Insulin glargine]] | ||
| + | *[[NovoLog]] - Generic: [[Insulin aspart]] | ||
| + | *[[Humalog]] - Generic: [[Insulin lispro]] | ||
=====Dipeptidyl Peptidase-4 Inhibitor===== | =====Dipeptidyl Peptidase-4 Inhibitor===== | ||
* [[Galvus]] - Generic: [[Vildagliptin]] | * [[Galvus]] - Generic: [[Vildagliptin]] | ||
Revision as of 12:16, 13 June 2023
Insulin
Dipeptidyl Peptidase-4 Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
|
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
